System for implanting a valve prosthesis

• US 7,789,909 B2
• Filed: 09/10/2009
• Issued: 09/07/2010
• Est. Priority Date: 05/18/1990
• Status: Expired due to Fees

• Current Assignee: Edwards Lifesciences AG (Edwards Lifesciences Corporation)
• Original Assignee: Edwards Lifesciences AG (Edwards Lifesciences Corporation)
• Inventors: Hasenkam, John Michael, Knudsen, Lars Lyhne, Andersen, Henning Rud
• Primary Examiner(s): Willse; David H.
• Application Number:
  US12/557,458
• Publication Number:
  US 20100004727A1
• Time in Patent Office: 362 Days
• Field of Search: 623 21- 219, 623 238- 241, 623/900, 623/904, 623 124- 126, 623/23.68, 623/FOR.101, 604/9
• US Class Current: 623/2.11
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/2433 using balloon catheter
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2220/005 using adhesives
• CPC Class Codes: A61F 2220/0058 soldered or brazed or welded
• CPC Class Codes: A61F 2230/0013 Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
• CPC Class Codes: Y10S 623/90 Stent for heart valve
• CPC Class Codes: Y10S 623/904 Heart

Abstract

A system for implanting a valve prosthesis comprises a compressible and expandable stent with a collapsible and expandable valve structure mounted within the stent. An insertion catheter is provided for advancing the valve prosthesis through a small inlet opening into a body channel The valve structure is preferably formed of biological tissue. The stent may be self-expandable or may be expanded by a balloon on the distal end portion of the catheter. The stent is configured to expand in the body channel such that the outer surface of the stent engages surrounding tissue. After expansion, the valve structure within the stent becomes functional, thereby allowing blood to flow in only one direction. The valve prosthesis is detachable from the catheter for permanent implantation in the body channel. The valve prosthesis is preferably used for replacing the function of a natural heart valve without requiring open heart surgery.

Claims

1. A system for replacing the function of a natural heart valve in a human body by a catheterization technique, comprising:

an elongate catheter having an opening configured for receiving a guide wire, the catheter sized for advancement into a human heart without opening the thoracic cavity;

a self-expandable stent constructed to be radially compressible and re-expandable, the stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and

a collapsible and re-expandable elastical valve comprising three flaps formed of biological tissue, the elastical valve attached to an interior portion of the stent for folding and expanding together with the stent, the elastical valve located between the top and bottom ends of the stent, the elastical valve having three commissural points sutured to the stent, the elastical valve configured to allow blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end;

wherein the stent and elastical valve are radially compressible from an expanded condition to a compressed condition for advancement through a small inlet opening into a body channel, the stent having a compressed outer diameter of 10 mm or less for placement inside a tubular wall of a cap along a distal end portion of the catheter and wherein the stent is radially self-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or more such that at least a portion of the stent contacts native tissue in the human heart for securing the stent in the human heart without suturing the stent to native tissue, the stent configured for supporting the elastical valve in the human heart for replacing the function of a natural aortic valve without open heart surgery and wherein the catheter is detachable from the stent and elastical valve such that the catheter can be removed from the human body and the small inlet opening can be closed such that the patient can resume a substantially normal life.

2. The system of claim 1, wherein the stent is configured to re-expand along an entire length of the stent.

3. The system of claim 2, wherein the elastical valve is sized to be positioned in the human heart between the coronary ostia and the left ventricle for replacing the function of the natural aortic valve.

4. The system of claim 3, wherein the stent has sufficient height such that a portion of the stent can be positioned above the coronary ostia while a remaining portion of the stent supports the elastical valve between the coronary ostia and the left ventricle.

5. The system of claim 4, wherein the stent has a thread structure.

6. The system of claim 5, wherein the thread structure is a grate shaped structure.

7. The system of claim 6, wherein the elastical valve comprises biological tissue from a pig heart.

8. The system of claim 7, wherein the stent has a stiffness sufficient to prevent a contraction of more than 10% following re-expansion.

9. The system of claim 1, wherein the elastical valve is glued to the stent.

10. A system for replacing the function of an aortic valve in an adult human heart using a catheterization technique and without requiring open heart surgery, comprising:

a flexible insertion catheter sized for insertion through a small inlet opening and configured for advancement over a guide wire through a body channel;

a radially compressible and re-expandable metallic stent having a top end, a bottom end and a metallic outer surface configured to directly contact surrounding native tissue in the body channel with a pressure sufficient to prevent detachment from the body channel; and

a radially collapsible and re-expandable valve positioned within an interior portion of the stent and sutured to the stent for folding and expanding together with the stent, the valve having three flaps formed of biological tissue, the three flaps positioned between the top and bottom ends of the stent for allowing blood to flow in one direction such that blood is capable of flowing through the stent from the bottom end toward the top end, the valve having three commissural points sutured to the stent;

wherein the stent is radially compressible from an expanded condition to a compressed condition, the compressed condition having a compressed outer diameter of less than 12.5 mm to be located inside a tubular wall of a cap along a distal end portion of the insertion catheter for advancement through the small inlet opening into the body channel and wherein the stent is radially re-expandable upon ejection from the cap to a re-expanded condition comprising a re-expanded outer diameter of approximately 27 mm or larger for securing the stent to the surrounding native tissue without suturing the stent to the surrounding native tissue and wherein the insertion catheter is detachable from the stent and valve such that the insertion catheter can be removed from the body channel and the small inlet opening can be closed and wherein the metallic stent has a sufficient height such that the top end of the stent is capable of being positioned downstream of the coronary ostia for anchoring the top end of the stent to the aorta while the valve is positioned substantially between the coronary ostia and a left ventricle of a heart for replacing the function of the natural aortic valve without requiring open heart surgery.

11. A system for replacing the function of a natural cardiac valve, comprising:

a flexible elongate delivery catheter having an opening configured to receive a guide wire, the catheter adapted for advancement into a human heart without opening the thoracic cavity; and

a valve prosthesis configured to be coupled to a distal end portion of the delivery catheter, the valve prosthesis comprising;

a radially compressible and re-expandable stent having a top end, a bottom end and a metallic outer surface configured to contact native tissue in the human heart; and

a collapsible and re-expandable valve structure positioned within an interior portion of the stent and sutured to the stent for collapsing and re-expanding together with the stent, the valve structure having three flaps formed entirely of biological tissue, the three flaps positioned between the top and bottom ends of the stent, the valve structure having three commissural points sutured to the stent, the valve structure configured to allow blood to flow in one direction such that blood enters through a bottom opening at the bottom end of the stent and exits through a top opening at the top end of the stent;

wherein the valve prosthesis is radially compressible to a compressed state comprising a compressed outer diameter of less than 10 mm for introduction by way of the delivery catheter through an inlet opening into a body channel and wherein the valve prosthesis is radially re-expandable to a re-expanded state comprising a re-expanded outer diameter at least three times larger than the compressed outer diameter and wherein the re-expanded outer diameter is sized to engage native tissue in the human heart with a pressure sufficient for preventing detachment from the human heart and for fixing the valve prosthesis in the human heart without suturing the valve prosthesis to native tissue and wherein the valve prosthesis is detachable from the delivery catheter such that the delivery catheter can be removed from the patient'"'"'s body and the inlet opening can be closed while the valve prosthesis remains in the human heart.

12. The system of claim 11, further comprising an expandable balloon disposed along the distal end portion of the delivery catheter, the expandable balloon configured to be inflated by injecting fluid through a fluid channel in the delivery catheter.

13. The system of claim 11, wherein the stent is self-expandable.

14. A system for replacing the function of a defective natural valve in an adult human, comprising:

an elongate insertion catheter having a central opening configured for receiving a guide wire, the catheter sized for advancement over the guide wire and through a body channel; and

a compressible and re-expandable stent having an inlet end, an outlet end and a metallic outer surface, the stent being radially compressible from an expanded state to a compressed state for introduction through an inlet opening into a body channel along a distal end portion of the insertion catheter, the stent being re-expandable along an entire length of the stent to a re-expanded state such that the metallic outer surface engages surrounding tissue in the body channel, wherein an outer diameter of the stent in the re-expanded state is at least three times larger than an outer diameter of the stent in the compressed state; and

a collapsible and re-expandable valve structure mounted within an interior portion of the stent between the inlet and outlet ends of the stent for folding and expanding together with the stent and configured for preventing blood flow in one direction, the valve structure having movable flaps positioned between the inlet and outlet ends of the stent for allowing blood to flow only from the inlet end toward the outlet end of the stent;

wherein stent stiffness provides the sole means of fixation to surrounding tissue for securing the stent and valve structure to the body channel and wherein the stent and valve structure are detachable from the catheter such that the catheter can be removed from the body channel and the inlet opening can be closed such that the stent and valve structure are permanently implantable in the body channel for replacing the function of a natural valve without suturing the stent or valve structure to surrounding native tissue.

15. The system according to claim 14, wherein the stent comprises a grate shaped structure.

16. The system according to claim 15, wherein the stent is self-expandable.

17. The system according to claim 16, wherein the valve structure is formed of biological tissue before the valve prosthesis is introduced through the inlet opening into the body channel.

18. The system according to claim 17, wherein the biological tissue forms two or more adjacent flaps, the flaps forming commissural points between adjacent flaps.

19. The system according to claim 18, wherein the stent further comprises an outlet end portion configured for fixation in the ascending aorta at a location downstream of the coronary ostia and an inlet end portion configured for positioning the valve structure substantially between the coronary ostia and the left ventricle.

20. The system according to claim 19, wherein at least the inlet end portion of the stent is substantially cylindrical.